Randomized, single-centered, phase II clinical trial of nimotuzumab plus cisplatin and S-1 as first-line therapy in patients with advanced gastric cancer.
Jin-Wan Wang
No relevant relationships to disclose
Yihebali Chi
No relevant relationships to disclose
Zhao-xu Zheng
No relevant relationships to disclose
Tao Qu
No relevant relationships to disclose
Ai-Ping Zhou
No relevant relationships to disclose
Lin Yang
No relevant relationships to disclose
Wen-chang Jiang
No relevant relationships to disclose
Shu-zhen Shi
No relevant relationships to disclose
Yong-kun Sun
No relevant relationships to disclose
Yan Song
No relevant relationships to disclose
Su-yi Kang
No relevant relationships to disclose